A CP 15,467 61 CEP of the European Pharmacopoeia monograph is often referred to as a CP 15,467 61 Certificate of Suitability (COS). The purpose of a CP 15,467 61 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of CP 15,467 61 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of CP 15,467 61 to their clients by showing that a CP 15,467 61 CEP has been issued for it. The manufacturer submits a CP 15,467 61 CEP (COS) as part of the market authorization procedure, and it takes on the role of a CP 15,467 61 CEP holder for the record. Additionally, the data presented in the CP 15,467 61 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the CP 15,467 61 DMF.
A CP 15,467 61 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. CP 15,467 61 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of CP 15,467 61 suppliers with CEP (COS) on PharmaCompass.